@techcrunch.com 4 years ago
Pitching accuracy rates of over 99% for multiple cancer screens, Thrive launches with $110 million
@xconomy.com 5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com 6 years ago
Tradewind Bioscience attacks the physiology of tumors to treat cancer